16th March 2017
Cloudtag (CTAG:LN), the Company that brings personal monitoring to the wellbeing, fitness and digital health markets wishes to reassure its shareholders that the Company and its directors remain fully committed to resolving the outstanding issues regarding its suspension from trading on AIM as soon as possible, and will provide an update to shareholders through the Regulatory Information Service (RIS) when appropriate.
Additionally, the Company wishes to assure shareholders that all staff are focussed on delivering Cloudtag’s first product, the Onitor Track, and the wider Company strategy of the digital health platform. As these matters progress, further updates will be made to shareholders in due course.
In the meantime, the Company’s directors request that all enquiries relating to the Company’s current situation are directed to investors@cloudtag.com, where the team will endeavour to respond as soon as they can. Please do be aware that they will not be able to provide any further information than that currently in the public domain.
Lastly, we would like to thank all shareholders for their continued support and patience as we work through this difficult period.
| Cloudtag Inc. Amit Ben-Haim | +1 345 949 45 44 contact@cloudtag.com |
| UK Investor Relations. | +44 (0) 20 7052 8469 investors@cloudtag.com |